Merck KGaA said it had been placed under formal investigation by a French court for possibly issuing misleading information regarding its thyroid drug product Levothyrox.
https://www.pharmalive.com/wp-content/uploads/2022/10/Merck-cyclist-2016.jpeg489800Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-10-19 05:55:082022-10-19 11:05:27Germany’s Merck under formal investigation in France over thyroid drug
